Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (610) Arrow Down
Filter Results: (610) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (610)
    • People  (4)
    • News  (110)
    • Research  (426)
    • Events  (3)
    • Multimedia  (4)
  • Faculty Publications  (259)

Show Results For

  • All HBS Web  (610)
    • People  (4)
    • News  (110)
    • Research  (426)
    • Events  (3)
    • Multimedia  (4)
  • Faculty Publications  (259)
← Page 18 of 610 Results →
  • 25 Feb 2014
  • First Look

First Look: February 25

Abstract—Researchers have long hypothesized that research outputs from government, university, and private company R&D contribute to economic growth, but these contributions may be difficult to measure when they take a non-pecuniary... View Details
Keywords: Sean Silverthorne
  • 01 Feb 1999
  • News

Too Much of a Good Thing?

layoffs and lost revenues, for example - weak companies are artificially supported," he explains. "Other firms won't or can't restructure themselves or exit unprofitable businesses because they are too set in their ways, lack sound... View Details
Keywords: Garry Emmons
  • 28 Jul 2008
  • Research & Ideas

Making the Decision to Franchise (or not)

appears to be true when you get a new type of consumer for the same product." In the pharmaceutical industry, for example, selling medicine to both an independent general practitioner and a hospital will require a different organizational... View Details
Keywords: by Julia Hanna; Retail
  • 22 Aug 2022
  • Research & Ideas

Can Amazon Remake Health Care?

need to do these [things] because we know patients respond to these financial barriers by cutting back on valuable care. Amazon’s not going to fix that problem. Amazon is good at selling other people’s products—but I don’t see it as a View Details
Keywords: by Christina Pazzanese, Harvard Gazette; Health
  • 28 Apr 2010
  • Research & Ideas

Earth Day Reflections

opportunity to engage in a virtual dialogue on these matters. Some major corporations are starting to take the lead in this effort, including United Technologies Corporation, Philips (the Dutch electronics and health care giant), the German chemical View Details
Keywords: by Staff
  • November 2023 (Revised April 2024)
  • Case

BiomX: Bringing Phage Back to the Stage

By: Paul A. Gompers, Elie Ofek, Orna Dan and Emilie Billaud
In the spring of 2023, and following the favorable results of a trial involving its phage cocktail for treating lung infections among cystic fibrosis (CF) patients, the leadership of BiomX had several critical issues to wrestle with. First, given its precarious... View Details
Keywords: Working Capital; Financing and Loans; Health Testing and Trials; Product Development; Research and Development; Science-Based Business; Commercialization; Pharmaceutical Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Gompers, Paul A., Elie Ofek, Orna Dan, and Emilie Billaud. "BiomX: Bringing Phage Back to the Stage." Harvard Business School Case 524-051, November 2023. (Revised April 2024.)
  • July 2016 (Revised July 2019)
  • Teaching Plan

Doctor My Eyes: The Acquisition of Bausch & Lomb by Warburg Pincus (A)

By: Nori Gerardo Lietz and Ricardo Andrade
In early 2010, senior partners at Warburg Pincus met to review a report on Bausch & Lomb Incorporated, the firm's largest investment at the time. Warburg Pincus had led a group of investors in acquiring Bauch & Lomb on October 26, 2007, taking the company private and... View Details
Keywords: Health Care; Mergers & Acquisitions; Governance; Buyout; Private Equity; Finance; Mergers and Acquisitions; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
Citation
Purchase
Related
Lietz, Nori Gerardo, and Ricardo Andrade. "Doctor My Eyes: The Acquisition of Bausch & Lomb by Warburg Pincus (A)." Harvard Business School Teaching Plan 217-003, July 2016. (Revised July 2019.)
  • April 2016 (Revised July 2019)
  • Case

"Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (A)

By: Nori Gerardo Lietz
In early 2010, senior partners at Warburg Pincus met to review a report on Bausch & Lomb Incorporated, the firm's largest investment at the time. Warburg Pincus had led a group of investors in acquiring Bauch & Lomb on October 26, 2007, taking the company private and... View Details
Keywords: Health Care; Mergers & Acquisitions; Governance; Buyout; Private Equity; Finance; Mergers and Acquisitions; Corporate Governance; Health Care and Treatment; Reports; Business Model; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
Citation
Educators
Related
Lietz, Nori Gerardo. "Doctor My Eyes"--The Acquisition of Bausch & Lomb by Warburg Pincus (A). Harvard Business School Case 216-021, April 2016. (Revised July 2019.)
  • 01 Jun 2023
  • News

From Big Pharma to Startup

pharmaceutical giant one day—not creating a company from scratch. But Goble was determined to explore the wide variety of opportunities available to him in his time at HBS, so when he read about a nonprofit... View Details
Keywords: April White
  • June 2012
  • Case

GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships

By: Arthur A. Daemmrich and Ian McKown Cornell
Three years into a major public-private partnership between GlaxoSmithKline and Fiocuz, Brazil's principal health institute, the company assesses technology transfer and joint research under the agreement. GSK was selling its Synflorix vaccine (against pediatric... View Details
Keywords: Public-Private Partnerships; Business and Government Relations; Foreign Direct Investment; Health Care and Treatment; Globalized Firms and Management; Pharmaceutical Industry; Pharmaceutical Industry; Brazil
Citation
Educators
Purchase
Related
Daemmrich, Arthur A., and Ian McKown Cornell. "GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships." Harvard Business School Case 712-049, June 2012.
  • 16 Oct 2007
  • First Look

First Look: October 16, 2007

this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=508036 Michael Fernandes at Nicholas Piramal Harvard Business School Case 408-001 Michael Fernandes, the Director of Custom Manufacturing Operations at the View Details
Keywords: Sean Silverthorne
  • Web

Value Measurement for Health Care - Institute For Strategy And Competitiveness

part of their business model Executives from health care insurance companies, government entities that pay for health care, or other payor organizations Leaders from pharmaceutical companies, medical device companies, or other health care... View Details
  • 08 Aug 2011
  • Research & Ideas

The Death of the Global Manager

that are part of operating in today's world." Envisioning The Future Bartlett describes Transnational Management as being in a constant state of evolution. The most recently added chapter, "The Future of the Transnational," includes a case study on the... View Details
Keywords: by Julia Hanna
  • 01 Oct 2021
  • News

From Scholarship to Life-Saving Impact

ending up with huge medical bills we couldn’t pay.” Inspired by this personal experience, Rabah chose to build a career in health care. She studied biology as an undergraduate at Cornell, where she developed a strong interest in drug pricing and View Details
  • 08 Feb 2000
  • Research & Ideas

Building Effective R&D Capabilities Abroad

capabilities and product portfolio, the company needed a dedicated laboratory site in East Asia. The new site would support efforts to manufacture and market pharmaceuticals by adapting products to local... View Details
Keywords: by Walter Kuemmerle
  • February 2009
  • Case

Avid Radiopharmaceuticals: The Venture Debt Question

By: Matthew Rhodes-Kropf and Ann Leamon
The CEO of a promising biotech company must decide how to respond to the macro-economic slump of late 2008. He had planned to pursue an aggressive schedule, moving the firm's Alzheimer's and Parkinson's disease imaging compounds through clinical trials and into the... View Details
Keywords: Financial Crisis; Entrepreneurship; Borrowing and Debt; Venture Capital; Financial Management; Investment; Health Testing and Trials; Expansion; Pharmaceutical Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Rhodes-Kropf, Matthew, and Ann Leamon. "Avid Radiopharmaceuticals: The Venture Debt Question." Harvard Business School Case 809-086, February 2009.
  • Web

Industry Information - Alumni

and user-generated content on companies and career issues. HBS alumni version available via eBaker. Covers information on case interviewing, a description of the industry, and profiles of the top 50 consulting firms. McKinsey Quarterly As... View Details
  • February 2005 (Revised April 2006)
  • Case

Rx Depot: Importing Drugs from Canada

By: Debora L. Spar
In 2002, a handful of entrepreneurs began to ship drugs from Canada into the United States, taking advantage of regulatory and price differentials across the neighboring countries. Using the Internet and a low-cost network of Canadian pharmacies, firms like Rx Depot... View Details
Keywords: Courts and Trials; Entrepreneurship; Intellectual Property; Laws and Statutes; Pharmaceutical Industry; Canada; United States
Citation
Find at Harvard
Related
Spar, Debora L., and Adam Day. "Rx Depot: Importing Drugs from Canada." Harvard Business School Case 705-010, February 2005. (Revised April 2006.)
  • 15 Dec 2003
  • Research & Ideas

The New Global Business Manager

The other is free. Through Project Hope, they seek out people who are suffering from this disease, in Africa or China, for example, and provide the therapy. This approach is in stark contrast to some of the big pharmaceutical View Details
Keywords: by Cynthia Churchwell
  • 22 Nov 2004
  • Research & Ideas

Side Effects: The Case of Propecia

"staggering" 90 percent brand awareness, she said. The problem: some of that awareness was driven by the much-publicized side effects issue. It was difficult for the drug maker to convey the true risk information necessary to blunt the side effects buzz. The... View Details
Keywords: by Sean Silverthorne; Pharmaceutical; Pharmaceutical
  • ←
  • 18
  • 19
  • …
  • 30
  • 31
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.